Roles of T lymphocytes in pulmonary fibrosis
The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Abstract
Infiltration of T lymphocytes in the lungs is common in patients with and in animal models of pulmonary fibrosis. The role of these cells in regulating the accumulation of extracellular matrix, particularly collagen, is not understood completely. Research literature provides evidence for a profibrotic, an antifibrotic, or no significant role of T lymphocytes in pulmonary fibrosis. This review offers a discussion of such evidence with the focus on phenotypes of pulmonary T lymphocytes and related profibrotic and antifibrotic mechanisms. It appears unlikely that T lymphocytic infiltration per se is the central driving force in most cases of pulmonary fibrosis. Instead, evidence suggests that T lymphocytes may modulate the inflammatory and healing responses in the lungs in a profibrotic or antifibrotic manner, depending on their phenotype. Phenotypic reshaping, rather than elimination of the infiltrating pulmonary T lymphocytes, may be a promising approach to improving outcomes in patients with pulmonary fibrosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Here, Th1 cells and their secretory products are thought of as being anti-fibrotic and Th2 cells and their mediators are considered pro-fibrotic (133).”
From The Role of Immune and Inflammatory Cells in Idiopathic Pulmonary Fibrosis (2018) · cites this paper as [133]
Citations
Cites
Incidence and Prevalence of Idiopathic Pulmonary Fibrosis
Raghu, G., Weycker, D., Edelsberg, J., Bradford, W. Z., & Oster, G. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200602-163oc · Cited by 1,310 · cited 2×
“new patients per year in the United States [2].”
BackgroundIdiopathic Pulmonary Fibrosis: Clinical Relevance of Pathologic Classification
KATZENSTEIN, A.-L. A., & MYERS, J. L. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.4.9707039 · Cited by 1,261
IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines
Molet, S., Hamid, Q., Davoineb, F., Nutku, E., Tahaa, R., Pagé, N., Olivenstein, R., Elias, J., & Chakir, J. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.117929 · Cited by 953 · cited 1×
“IL-17 enhances production of cytokines in cultured, pulmonary fibroblasts but appears to have no direct effect on fibroblast proliferation or collagen production [52].”
BackgroundA placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis
Raghu, G., Brown, K. K., Bradford, W. Z., Starko, K., Noble, P. W., Schwartz, D. A., & King, T. E. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa030511 · Cited by 652
Tumor necrosis factor/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis.
Piguet, P. F., Collart, M. A., Grau, G. E., Kapanci, Y., & Vassalli, P. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.3.655 · Cited by 583 · cited 1×
“In contrast, different studies in the bleomycin model reported that depletion of T cells prevents collagen accumulation [34] or diminishes pulmonary fibrosis and increases survival [35].”
ResultA Vicious Circle of Alveolar Macrophages and Fibroblasts Perpetuates Pulmonary Fibrosis via CCL18
Prasse, A., Pechkovsky, D. V., Toews, G. B., Jungraithmayr, W., Kollert, F., Goldmann, T., Vollmer, E., Müller-Quernheim, J., & Zissel, G. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200509-1518oc · Cited by 497 · cited 1×
“For example, activation of alveolar macrophages with type 2 cytokines skews their phenotype toward so-called alternative activation, and alternatively activated macrophages are themselves profibrotic [49] through production of various cytokines including profibrotic chemokines CCL2 [42] and CCL18 [50, 51].”
BackgroundBleomycin-induced interstitial pulmonary disease in the nude, athymic mouse.
Szapiel, S. V., Elson, N., Fulmer, J. D., Hunninghake, G. W., & Crystal, R. G. (1979) · PubMed · doi:10.1164/arrd.1979.120.4.893 · Cited by 463 · cited 1×
“Mice with genetic defects manifesting in a total lack of T lymphocytes, such as athymic (nude) mice [27] and SCID mice [28], developed alveolitis and pulmonary fibrosis in response to bleomycin, similar to that in normal (wild-type) mice.”
BackgroundDANIIL, Z. D., GILCHRIST, F. C., NICHOLSON, A. G., HANSELL, D. M., HARRIS, J., COLBY, T. V., & du BOIS, R. M. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.3.9903021 · Cited by 381
Mart�nez-Lav�n, M., Hermosillo, A. G., Rosas, M., & Soto, M.-E. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199811)41:11<1966::aid-art11>3.0.co;2-o · Cited by 306
Structural Features of Interstitial Lung Disease in Systemic Sclerosis
Harrison, N. K., Myers, A. R., Corrin, B., Soosay, G., Dewar, A., Black, C. M., Du Bois, R. M., & Turner-Warwick, M. (1991) · American Review of Respiratory Disease · doi:10.1164/ajrccm/144.3_pt_1.706 · Cited by 251 · cited 2×
“Pulmonary fibrosis often occurs in association with systemic connective tissue diseases, particularly scleroderma [4, 12], rheumatoid arthritis (RA) [14], and polymyositis/dermatomyositis [15, 16].”
Background
Research works printed but not linked: 1
- Huaux, 2007, ThIL-17 cells contribute to alveolitis but are not instrumental in fibrosis development, Am. J. Respir. Crit. Care Med., 175, A737
Cited by
Shared and distinct mechanisms of fibrosis
Distler, J. H. W., Györfi, A.-H., Ramanujam, M., Whitfield, M. L., Königshoff, M., & Lafyatis, R. (2019) · Nature Reviews Rheumatology · doi:10.1038/s41584-019-0322-7 · Cited by 637
Regulation of inflammation by interleukin-4: a review of "alternatives"
Luzina, I. G., Keegan, A. D., Heller, N. M., Rook, G. A. W., Shea-Donohue, T., & Atamas, S. P. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.0412214 · Cited by 351
Self-citationImmune mechanisms in pulmonary fibrosis
Kolahian, S., Fernandez, I. E., Eickelberg, O., & Hartl, D. (2016) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2016-0121tr · Cited by 349
T Cells in Fibrosis and Fibrotic Diseases
Zhang, M., & Zhang, S. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01142 · Cited by 330
“However, the functions of each T cell subset appear to be perplexing and are influenced by interactions with epithelial cells or fibroblasts, the pulmonary localization of fibrosis in the bronchial or alveolar region, and the disease progression stage (9, 10).”
BackgroundThe Role of Immune and Inflammatory Cells in Idiopathic Pulmonary Fibrosis
Desai, O., Winkler, J., Minasyan, M., & Herzog, E. L. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00043 · Cited by 314
“Here, Th1 cells and their secretory products are thought of as being anti-fibrotic and Th2 cells and their mediators are considered pro-fibrotic (133).”
Background
Metadata
- Authors
- Luzina, I. G., Todd, N. W., Iacono, A. T., & Atamas, S. P.
- Affiliations
- Baltimore VA Medical Center (US)
- Corresponding author
- Atamas, Sergei P
- Venue
- Journal of Leukocyte Biology
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-10-25
- Volume
- 83
- Issue
- 2
- Pages
- 237-244
- ISSN
- 0741-5400 (ISSN-L)
- 1938-3673
- OpenAlex
- W2164998164
- Cited by
- 163
- References
- 59
- Citations by year
- 2026: 4 · 2025: 7 · 2024: 7 · 2023: 12 · 2022: 12 · 2021: 7 · 2020: 9 · 2019: 7 · 2018: 13 · 2017: 9 · 2016: 8 · 2015: 10 · 2014: 8 · 2013: 10 · 2012: 12
- FWCI
- 0.95
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Leukocyte Biology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (1R01HL074067)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
- Keywords
- pulmonary fibrosis, T cells, T cell phenotype, extracellular matrix accumulation, collagen deposition, antifibrotic mechanism, lung inflammation
- MeSH terms
- Animals, Connective Tissue Diseases, Disease Models, Animal, Extracellular Matrix, Humans, Inflammation, Lymphocyte Depletion, Lymphokines, Mice, Nude, Pulmonary Fibrosis, T-Lymphocyte Subsets, Mice, SCID, Lung Diseases, Interstitial, CD28 Antigens, Mice, Knockout, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Roles of T lymphocytes in pulmonary fibrosis. https://app.cochat.ai/papers/10.1189/jlb.0707504
- The paper
- Luzina, I. G., Todd, N. W., Iacono, A. T., & Atamas, S. P. (2008). Roles of T lymphocytes in pulmonary fibrosis. Journal of Leukocyte Biology. https://doi.org/10.1189/jlb.0707504
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.